Indian Immunologicals wins DCGI okay to manufacture Measles-Rubella vaccine
This vaccine has been proven through extensive human clinical trials to be immunogenic and safe for people of 9 months to 49 years, it said.;
Hyderabad: Indian Immunologicals Limited (IIL), a city-based vaccine maker has announced receipt of approval from Drugs Controller General of India and State Drug Control Administration for manufacturing of Measles-Rubella (MR) Vaccine.
A press release from IIL said, "IIL's Indo-Vietnam Partnership resulted in manufacturing and marketing authorisation of their Measles-Rubella (MR) Vaccine. IIL partnered with Center for Research and Production of Vaccines and Biologicals, also called Polyvac, Vietnam".
Under an exclusive agreement, Polyvac, Vietnam will supply the Measles vaccine component to IIL. Rubella Vaccine component will be produced by IIL to manufacture a combined MR vaccine, it said.
This Live Attenuated MR vaccine adds to the list of several other vaccines that IIL supplies to Universal Immunization Programme (UIP) of India, the release said.
This vaccine has been proven through extensive human clinical trials to be immunogenic and safe for people of 9 months to 49 years, it said.
Read also: Indian Immunologicals launches its first set of virtual medical representatives
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.